# FDA Inspection 1198516 - Octapharma Plasma Inc - February 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/d8debd98-b2e6-49a8-ba4f-4ad4f03aefd7
Source feed: FDA_Inspections

> FDA Inspection 1198516 for Octapharma Plasma Inc on February 14, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1198516
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2023-02-14
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1283886 - 2025-10-14](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/5dd0fbb8-2e31-4481-b495-1d957767bdb8)
- [FDA Inspection 1283886 - 2025-10-14](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/4dcd04ea-3849-4bcd-a841-2851c1c2ae90)
- [FDA Inspection 1198516 - 2023-02-14](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/74b44c98-0e8c-437e-9cc4-d01b0c783af5)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/94c28953-af82-44dd-8551-cdf7a9da06a8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d